Affordability impacts therapeutic intensity of acute management of severe traumatic brain injury patients: An exploratory study in Tanzania.

Publication Type Academic Article
Authors Schenck H, Joackim P, Lazaro A, Wu X, Gerber L, Stieg P, Härtl R, Shabani H, Mangat H
Journal Brain Spine
Volume 3
Pagination 101738
Date Published 04/06/2023
ISSN 2772-5294
Abstract INTRODUCTION: Quality health care in low and middle-income countries (LMICs) is constrained by financing of care. RESEARCH QUESTION: What is the effect of ability to pay on critical care management of patients with severe traumatic brain injury (sTBI)? MATERIAL AND METHODS: Data on sTBI patients admitted to a tertiary referral hospital in Dar-es-Salaam, Tanzania, were collected between 2016 and 2018, and included payor mechanisms for hospitalization costs. Patients were grouped as those who could afford care and those who were unable to pay. RESULTS: Sixty-seven patients with sTBI were included. Of those enrolled, 44 (65.7%) were able to pay and 15 (22.3%) were unable to pay costs of care upfront. Eight (11.9%) patients did not have a documented source of payment (unknown identity or excluded from further analysis). Overall mechanical ventilation rates were 81% (n=36) in the affordable group and 100% (n=15) in the unaffordable group (p=0.08). Computed tomography (CT) rates were 71.6% (n=48) overall, 100% (n=44) and 0% respectively (p<0.01); Surgical rates were 16.4% (n=11) overall, 18.2% (n=8) vs. 13.3% (n=2) (p=0.67) respectively. Two-week mortality was 59.7% overall (n=40), 47.7% (n=21) in the affordable group and 73.3% (n=11) in the unaffordable group (p=0.09) (adjusted OR 0.4; 95% CI: 0.07-2.41, p=0.32). DISCUSSION AND CONCLUSION: Ability to pay appears to have a strong association with the use of head CT and a weak association with mechanical ventilation in the management of sTBI. Inability to pay increases redundant or sub-optimal care, and imposes a financial burden on patients and their relatives.
DOI 10.1016/j.bas.2023.101738
PubMed ID 37383438
PubMed Central ID PMC10293321
Back to Top